Driven by the increasing cases of COPD, OSA, and the ever-increasing global elderly population, coupled with the increase in the number of surgeries and rise in hospital admission for respiratory diseases, the global Anesthesia and Respiratory devices market is anticipated to exhibit a CAGR of 6.14% by the end of the forecast period of 2018-2026.
The Global Anesthesia and Respiratory devices market segmentation is done on the basis of product types. Their further sub-segmentation is done into respiratory devices, respiratory disposables, respiratory measurement devices, airway and anesthesia devices, regional anesthesia disposables, anesthesia machines, pain management devices, sleep apnea diagnostic devices and portable polysomnography system. Opportunities like the scope for product innovations and developments in emerging markets are expected to drive growth in the global market over the projected years. However, stringent regulation and lack of proper training and reimbursement are restraining the market growth.
North America, Europe, Asia-Pacific and rest of the world are the regions into which the global Anesthesia and Respiratory devices market has been segmented. Over the course of the forecast period of 2018-2026, the highest growth is expected from the Asia-Pacific market. Asian countries like China, India and Japan have the highest number of elderly population. Also, in the past few years, the region has been witnessing an increasing awareness about healthcare, which is increasingly contributing to its market growth. In terms of revenue generation, the North American Anesthesia and Respiratory devices market is expected to continue its dominance by 2026.
Some of the key companies operating in this region are Ambu A/S, B. Braun Melsungen Ag, Becton, Dickinson, And Co, Draegerwerk Ag & Co. Kgaa, Fisher & Paykel Healthcare, Ge Healthcare, Halyard Health Inc, Invacare Corp, Medtronic, Philips Respironics, Resmed Inc, Smiths Medical, and Teleflex.